20/20 Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$314K Buy
1,289
+61
+5% +$15K 0.08% 130
2021
Q1
$306K Hold
1,228
0.09% 130
2020
Q4
$295K Buy
1,228
+31
+3% +$7.15K 0.09% 135
2020
Q3
$304K Buy
1,197
+2
+0.2% +$495 0.11% 119
2020
Q2
$288K Buy
1,195
+80
+7% +$18.3K 0.11% 110
2020
Q1
$260K Buy
1,115
+3
+0.3% +$655 0.12% 122
2019
Q4
$257K Buy
+1,112
New +$245K 0.1% 128

Other funds holding AMGN

20/20 Capital Management's AMGN Position: Q2 2021 in Review

20/20 Capital Management increased its Amgen (AMGN) stake by 5% in Q2 2021, buying an estimated $15K and bringing the position to 1,289 shares worth $314K. The position accounts for 0.08% of the portfolio, ranked #130.

20/20 Capital Management first reported a position in AMGN in Q4 2019 and has held it in 7 quarters since. 2,196 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • 20/20 Capital Management held 1,289 shares of Amgen worth $314K as of Q2 2021.
  • 20/20 Capital Management bought 61 Amgen shares in Q2 2021, an estimated $15K.
  • Amgen made up 0.08% of 20/20 Capital Management's portfolio in Q2 2021, its #130 holding.
  • 20/20 Capital Management first reported a position in Amgen in Q4 2019 and has held it in 7 quarters since.
  • 2,196 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on 20/20 Capital Management's 13F filing for Q2 2021, filed 12 Jul 2021.